Adapting Versatile Opportunities for Glycopeptide Antibiotics
- Funder: MRC
- Years: December 2025 to December 2028
- Role: Investigator
- Lead: J. Lewandowski
- Grant: UKRI877
Funding and Partners
Our research on membrane proteins and the bacterial cell envelope is made possible by the generous support of our funders and partners. We are grateful to the organisations below for supporting our work and our people.
Research councils
Multidisciplinary toolbox for characterising lipid II binding antibiotics
- Funder: EPSRC
- Years: April 2025 to March 2028
- Role: Investigator
- Lead: J. Lewandowski
- Grant: UKRI8021
FtsEX–PcsB: a protein complex required for cell division in S. pneumoniae
- Funder: MRC
- Years: November 2024 to October 2027
- Role: Investigator
- Lead: D. Roper
- Grant: UKRI8447
HetSys II: Centre for Doctoral Training in Modelling of Heterogeneous Systems
- Funder: EPSRC
- Years: October 2024 to March 2033
- Role: Investigator
- Grant: EP/Y035429/1
Optimal cell factories for membrane protein production
- Funder: BBSRC Engineering Biology Mission Award
- Years: May 2024 to June 2029
- Role: Investigator
- Lead: A. Darlington
- Grant: BB/Y007603/1 and its continuation BB/Y007603/2
Cell wall formation in rod-shaped bacteria
- Funder: BBSRC strategic Longer and Larger (sLoLa) award
- Years: March 2024 to February 2029
- Role: Investigator
- Lead: D. Roper
- Grant: UKRI8814
- More: Announcement
Antimicrobial Resistance: Breakthrough Compound Discovery through Mechanistic Studies combined with Bicycle Technology and Target Validation
- Funder: BBSRC
- Years: November 2023 to April 2027
- Role: Investigator
- Lead: C. Dowson
- Grant: UKRI7041
PhD studentships
Earlier support
- Wellcome: Postdoctoral research, University of Oxford, 2007 to 2010
- BBSRC: Researcher Co-Investigator award to build MemProtMD, 2011 to 2014
- BBSRC, MRC and Wellcome: Research funding during an independent fellowship in Oxford, 2015 to 2019
Charities and fellowships
Great Britain Sasakawa Foundation
- Award: £1.5 million donation to the Sir Howard Dalton Centre
- Supports: UK–Japan collaboration on antimicrobial resistance research and the training of researchers, through the Centre
- Announced: March 2024
- Links: Sir Howard Dalton Centre · News: £1.5m donation drives UK–Japan collaboration (March 2024)
Philanthropy
The Sir Howard Dalton Centre
- With thanks to: Dr David Stirling
- Thanks: We are deeply grateful to Dr David Stirling, a Warwick alumnus and Sir Howard Dalton’s first PhD student, whose generous gift established the Sir Howard Dalton Centre for Translational Mechanistic Enzymology in 2022. A further £1.2 million gift in 2026 provides sustainable funding for the Centre, which Phill co-directs with Chris Dowson.
- Links: Sir Howard Dalton Centre · News: £1.2 million donation (March 2026)
Industry partners
Bicycle Therapeutics
- What we do together: Designing Bicycle binders to novel cell envelope targets, as part of the search for new antimicrobials. The collaboration supports an MRC DTP PhD student and postdoctoral research in the group.
- Related grant: Antimicrobial Resistance: Breakthrough Compound Discovery through Mechanistic Studies combined with Bicycle Technology and Target Validation (BBSRC, led by C. Dowson, UKRI7041), November 2023 to April 2027
- Link: bicycletherapeutics.com
Computing
Our simulations rely on national and regional high-performance computing. We gratefully acknowledge:
- Warwick’s Scientific Computing Research Technology Platform (SCRTP), for local computing including the Avon cluster.
- Sulis, the Tier 2 HPC platform hosted by SCRTP at the University of Warwick, funded by EPSRC (EP/T022108/1) and the HPC Midlands+ consortium.
- HECBioSim, the UK High-End Computing Consortium for Biomolecular Simulation, which provides access to national supercomputers such as ARCHER2, with support from EPSRC.
Join us
Interested in a funded PhD studentship or a collaboration? See our Positions page or get in touch.